Engineered gene clusters for the production of the antimicrobial peptide microcin J25

被引:35
作者
Pan, Si Jia [1 ]
Cheung, Wai Ling [1 ]
Link, A. James [1 ,2 ]
机构
[1] Princeton Univ, Dept Chem Engn, Princeton, NJ 08544 USA
[2] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA
关键词
Microcin J25; Gene cluster; Microcin; Antimicrobial peptide; Posttranslational modification; ENCODED ANTIBACTERIAL PEPTIDES; BACTERIAL RNA-POLYMERASE; ESCHERICHIA-COLI; PROTEIN; ENTEROBACTERIA; EXPRESSION; MATURATION; DIVERSITY; TAIL;
D O I
10.1016/j.pep.2009.12.010
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Microcin J25 (MccJ25) is an antimicrobial peptide produced by isolates of Escherichia colt with activity against closely related species. Production and export of mature MccJ25 in E. coli requires four genes that are organized on a plasmid-borne cluster in natural producer strains. In these strains, MccJ25 production does not commence until the cells reach stationary phase, and, according to previous literature, the highest titers of MccJ25 are obtained from cells grown in nutrient-poor medium. We sought to design an engineered MccJ25 gene cluster that alleviated the growth phase and media limitations of the natural cluster. In contrast to previous reports, we observe here that production of MccJ25 from its natural cluster is efficient in rich media, such as Luria Bertani (LB). The engineered gene cluster functions in several E. coli strains and produces titers of MccJ25 that are moderately increased (1.5- to 2-fold) relative to the natural cluster. RT-PCR experiments and translational GFP fusion experiments confirm that the engineered cluster produces MccJ25 throughout exponential phase. Furthermore, we provide evidence that control of the natural MccJ25 gene cluster is at the transcriptional level. The observations herein provide design parameters for large-scale production of MccJ25 for biotechnological applications. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:200 / 206
页数:7
相关论文
共 28 条
[21]  
SALOMON RA, 1994, FEMS MICROBIOL LETT, V121, P275, DOI 10.1016/0378-1097(94)90303-4
[22]   THE PEPTIDE ANTIBIOTIC MICROCIN-25 IS IMPORTED THROUGH THE TONB PATHWAY AND THE SBMA PROTEIN [J].
SALOMON, RA ;
FARIAS, RN .
JOURNAL OF BACTERIOLOGY, 1995, 177 (11) :3323-3325
[23]  
SALOMON RA, 1993, J BACTERIOL, V175, P7741
[24]   Genetic analysis of plasmid determinants for microcin J25 production and immunity [J].
Solbiati, JO ;
Ciaccio, M ;
Farias, RN ;
Salomon, RA .
JOURNAL OF BACTERIOLOGY, 1996, 178 (12) :3661-3663
[25]   Sequence analysis of the four plasmid genes required to produce the circular peptide antibiotic microcin J25 [J].
Solbiati, JO ;
Ciaccio, M ;
Farías, RN ;
González-Pastor, JE ;
Moreno, F ;
Salomón, RA .
JOURNAL OF BACTERIOLOGY, 1999, 181 (08) :2659-2662
[26]   Protein production by auto-induction in high-density shaking cultures [J].
Studier, FW .
PROTEIN EXPRESSION AND PURIFICATION, 2005, 41 (01) :207-234
[27]   Structure of microcin J25, a peptide inhibitor of bacterial RNA polymerase, is a lassoed tail [J].
Wilson, KA ;
Kalkum, M ;
Ottesen, J ;
Yuzenkova, J ;
Chait, BT ;
Landick, R ;
Muir, T ;
Severinov, K ;
Darst, SA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (41) :12475-12483
[28]   Mutations of bacterial RNA polymerase leading to resistance to microcin J25 [J].
Yuzenkova, J ;
Delgado, M ;
Nechaev, S ;
Savalia, D ;
Epshtein, V ;
Artsimovitch, I ;
Mooney, RA ;
Landick, R ;
Farias, RN ;
Salomon, R ;
Severinov, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (52) :50867-50875